The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence.
- Published in:
- Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 2, p. 61, doi. 10.1177/1758834011432949
- By:
- Publication type:
- Article
Works matching IS 17588340 AND DT 2012 AND VI 4 AND IP 2
Results: 4
1
2
Ipilimumab: its potential in non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 2, p. 43, doi. 10.1177/1758834011431718
- By:
- Publication type:
- Article
3
Therapeutic strategy in unresectable metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 2, p. 75, doi. 10.1177/1758834011431592
- By:
- Publication type:
- Article
4
Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls.
- Published in:
- Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 2, p. 51, doi. 10.1177/1758834011427576
- By:
- Publication type:
- Article